Nasus Pharma Ltd. carries a market capitalization of 32.17M, placing it among publicly traded companies globally.
| Market Cap | 32.17M |
| Enterprise Value | N/A |
Nasus Pharma Ltd.'s stock has declined approximately -53.37079% over the past 52 weeks. The 50-day moving average sits at 3.41, while the 200-day moving average is 4.37.
| Beta (5Y) | N/A |
| 52-Week Price Change | -53.37079% |
| 50-Day Moving Average | 3.41 |
| 200-Day Moving Average | 4.37 |
| Average Volume (20 Days) | N/A |